Autoimmune Diseases  >>  insulin peglispro (LY2605541)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
insulin peglispro (LY2605541) / Eli Lilly
NCT01049412: A Study for Patients With Type 1 Diabetes

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark P2 data
Nov 2012 - Nov 2012: P2 data
Checkmark P2 data- EASD
More
Completed
2
138
US, RoW
LY2605541, Insulin glargine
Eli Lilly and Company
Diabetes Mellitus, Type 1
12/10
01/11

Download Options